Your browser's JavaScript is disabled.

To properly view the content on this page, please enable JavaScript.

Publications

ASH 2019

All Publications

IMerge: A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) that is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

Clinical Imetelstat: MDS Imetelstat

Platzbecker, et al.

Combination Treatment with Imetelstat, a Telomerase Inhibitor, and Ruxolitinib Depletes Myelofibrosis Hematopoietic Stem Cells and Progenitor Cells

Clinical Imetelstat: MF Imetelstat Non-clinical Imetelstat

Wang, X, et al.

[facetwp facet="publication_load_more"]